Fuso Pharmaceutical Industries,Ltd. (4538.T) JPX

Currency In JPY

AD

Valuation

Market Cap20.18B
Enterprise Value43.79B
P/E Ratio8.97
PEG Ratio0.07
Price/Sales Ratio0.31
Price/Book Ratio0.55
Enterprise/Revenue0.66
Enterprise/EBITDA7.32

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.03
Operating Margin0.05
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.06

Income Statement

Revenue62.31B
Revenue/Share7,362.43
Gross Profit16B
EBITDA5.38B
Net Income2.01B
Diluted EPS235.52

Balance Sheet

Total Cash4.57B
Total Cash/Share535.81
Total Debt26.31B
Total Debt/Equity0.74
Current Ratio1.12
Book Value Per Share4,188.32

Price History

52-Week Change3.79
52-Week High2,530
52-Week Low1,990
Moving Average 50 Days2,158.46
Moving Average 200 Days2,240.98

Statistics

Average Volume17,511
Shares Outstanding8.54M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate90
Trailing Annual Dividend Yield3.91
Payout Ratio0
Last Split Factor1:10
Last Split DateSeptember 28, 2016
AD